AMNEAL PHARMACEUTICALS, INC Net Profit Margin 2009-2021 | AMRX

AMNEAL PHARMACEUTICALS, INC net profit margin from 2009 to 2021. Net profit margin can be defined as net Income as a portion of total sales revenue.
AMNEAL PHARMACEUTICALS, INC Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2021-09-30 $2.07B $0.02B 0.73%
2021-06-30 $2.06B $0.01B 0.49%
2021-03-31 $1.99B $-0.02B -0.86%
2020-12-31 $1.99B $0.09B 4.57%
2020-09-30 $1.88B $0.06B 3.30%
2020-06-30 $1.74B $-0.19B -11.16%
2020-03-31 $1.68B $-0.20B -11.85%
2019-12-31 $1.63B $-0.36B -22.26%
2019-09-30 $1.73B $-0.34B -19.63%
2019-06-30 $1.83B $-0.07B -3.67%
2019-03-31 $1.83B $-0.07B -3.76%
2018-12-31 $1.66B $-0.02B -1.26%
2018-09-30 $1.50B $-0.01B -0.80%
2018-06-30 $1.28B $-0.02B -1.49%
2018-03-31 $1.13B 0 0.00%
2017-12-31 $1.03B $-0.10B -9.48%
2017-09-30 $1.09B $0.09B 8.62%
2017-06-30 $1.06B $-0.09B -7.99%
2017-03-31 $0.98B $-0.09B -9.01%
2016-12-31 $1.02B 0 0.00%
2016-09-30 $0.91B $-0.18B -19.91%
2016-06-30 $0.90B $0.03B 3.77%
2016-03-31 $0.94B $0.04B 3.71%
2015-12-31 $0.86B $0.04B 4.53%
2015-09-30 $0.71B $0.03B 3.95%
2015-06-30 $0.65B $0.01B 1.24%
2015-03-31 $0.62B $0.05B 7.26%
2014-12-31 $0.60B $0.06B 9.56%
2014-09-30 $0.57B $0.05B 8.30%
2014-06-30 $0.54B $0.03B 5.73%
2014-03-31 $0.48B $0.00B 0.41%
2013-12-31 $0.51B $0.10B 19.73%
2013-09-30 $0.55B $0.12B 21.01%
2013-06-30 $0.57B $0.14B 24.07%
2013-03-31 $0.60B $0.15B 24.79%
2012-12-31 $0.58B $0.06B 9.62%
2012-09-30 $0.60B $0.07B 12.17%
2012-06-30 $0.57B $0.07B 12.20%
2012-03-31 $0.53B $0.06B 11.99%
2011-12-31 $0.51B $0.07B 12.84%
2011-09-30 $0.45B $0.06B 12.33%
2011-06-30 $0.64B $0.11B 17.87%
2011-03-31 $0.67B $0.13B 19.85%
2010-12-31 $0.88B $0.25B 28.33%
2010-09-30 $0.96B $0.28B 28.77%
2010-06-30 $0.72B $0.21B 28.87%
2010-03-31 $0.62B $0.18B 28.78%
2009-12-31 $0.36B $0.05B 13.97%
2009-09-30 $0.23B $0.02B 9.25%
2009-06-30 $0.20B $0.00B 1.51%
2009-03-31 $0.22B $0.02B 7.73%
2008-12-31 $0.21B $0.02B 7.11%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.278B $1.993B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $106.785B 48.96
Takeda Pharmaceutical (TAK) Japan $43.860B 7.18
Catalent (CTLT) United States $21.140B 40.22
Stevanato Group S.p.A (STVN) Italy $6.778B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.022B 15.73
USANA Health Sciences (USNA) United States $1.957B 15.35
Rafael Holdings (RFL) United States $0.124B 0.00
Lannett Co Inc (LCI) United States $0.089B 0.00